Covidien Ltd Company Profile (NYSE:COV)

About Covidien Ltd (NYSE:COV)

Covidien Ltd logoCovidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company's brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company's segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company's products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:COV
  • CUSIP: G2554F11
  • Web: N/A
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0
Dividend:
  • Dividend Yield: 1.0%
Profitability:
  • Net Margins: 19.02%
  • Return on Equity: 20.06%
  • Return on Assets: 9.92%
 

Frequently Asked Questions for Covidien Ltd (NYSE:COV)

What is Covidien Ltd's stock symbol?

Covidien Ltd trades on the New York Stock Exchange (NYSE) under the ticker symbol "COV."

How were Covidien Ltd's earnings last quarter?

Covidien Ltd (NYSE:COV) released its earnings results on Wednesday, November, 5th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.13. The business had revenue of $2.73 billion for the quarter, compared to analyst estimates of $2.69 billion. Covidien Ltd had a return on equity of 20.06% and a net margin of 19.02%. Covidien Ltd's revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.91 earnings per share. View Covidien Ltd's Earnings History.

Who are some of Covidien Ltd's key competitors?

Who are Covidien Ltd's key executives?

Covidien Ltd's management team includes the folowing people:

  • Gary L. Ellis, President, Chief Executive Officer
  • Charles J. Dockendorff, Chief Financial Officer, Executive Vice President
  • Bryan C. Hanson, Group President, Covidien
  • John H. Masterson, Senior Vice President, General Counsel
  • Michael P. Dunford, Senior Vice President - Human Resources
  • James C. Clemmer, Senior Vice President and President - Medical Supplies Business
  • Amy A. McBride-Wendell, Senior Vice President - Strategy and Business Development
  • Jacqueline F. Strayer, Senior Vice President-Corporate Communications
  • Michael E. Tarnoff, Senior Vice President,Chief Medical Officer
  • Peter L. Wehrly, Senior Vice President, Group President - Developed Markets

How do I buy Covidien Ltd stock?

Shares of Covidien Ltd can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Covidien Ltd's stock price today?

One share of Covidien Ltd stock can currently be purchased for approximately $108.07.


MarketBeat Community Rating for Covidien Ltd (NYSE COV)
Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  305 (Vote Outperform)
Underperform Votes:  151 (Vote Underperform)
Total Votes:  456
MarketBeat's community ratings are surveys of what our community members think about Covidien Ltd and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Covidien Ltd (NYSE:COV) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Covidien Ltd (NYSE:COV)
Price Target History for Covidien Ltd (NYSE:COV)
Analysts' Ratings History for Covidien Ltd (NYSE:COV)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Covidien Ltd (NYSE:COV)
Earnings by Quarter for Covidien Ltd (NYSE:COV)
Earnings History by Quarter for Covidien Ltd (NYSE COV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/22/2015Q115$1.04$1.11$2.72 billion$2.69 billionViewN/AView Earnings Details
11/5/2014Q414$1.02$1.15$2.69 billion$2.73 billionViewListenView Earnings Details
7/25/2014Q314$1.00$1.04$2.69 billion$2.69 billionViewListenView Earnings Details
4/25/2014Q214$0.95$0.96$2.61 billion$2.60 billionViewListenView Earnings Details
1/24/2014Q114$0.94$1.00$2.61 billion$2.64 billionViewListenView Earnings Details
8/1/2013Q3 2013$0.89$0.85$2.58 billion$2.58 billionViewListenView Earnings Details
4/26/2013Q2 2013$1.09$1.12$3.12 billion$3.10 billionViewListenView Earnings Details
1/25/2013Q1 2013$1.06$1.10$3.00 billion$3.06 billionViewListenView Earnings Details
11/9/2012Q412$1.00$1.02$2.98 billion$3.00 billionViewN/AView Earnings Details
7/26/2012$1.06$1.07ViewN/AView Earnings Details
4/27/2012$1.03$1.05ViewN/AView Earnings Details
1/26/2012$1.03$1.13ViewN/AView Earnings Details
11/15/2011$1.05$1.08ViewN/AView Earnings Details
7/26/2011$0.94$1.01ViewN/AView Earnings Details
4/21/2011$0.89$0.93ViewN/AView Earnings Details
2/1/2011$0.81$0.95ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Covidien Ltd (NYSE:COV)
Current Year EPS Consensus Estimate: $0.00 EPS
Next Year EPS Consensus Estimate: $0.00 EPS

Dividends

Current Dividend Information for Covidien Ltd (NYSE:COV)
Most Recent Dividend:1/16/2015
Dividend Yield:0.00%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:NaN (Based on This Year's Estimates)
NaN (Based on Next Year's Estimates)
Track Record:8 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Covidien Ltd (NYSE:COV)

Dividend History by Quarter for Covidien Ltd (NYSE COV)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/19/2014quarterly$0.361.38%12/30/20141/2/20151/16/2015
9/17/2014quarterly$0.361.59%10/3/201410/7/201411/6/2014
7/16/2014quarterly$0.321.47%7/25/20147/29/20148/19/2014
3/19/2014quarterly$0.324/3/20144/7/20145/5/2014
1/16/2014quarterly$0.321.88%1/24/20141/28/20142/20/2014
9/19/2013quarterly$0.322.03%10/8/201310/10/201311/5/2013
7/17/2013quarterly$0.261.71%7/26/20137/30/20138/15/2013
3/21/2013quarterly$0.261.56%4/2/20134/4/20135/3/2013
12/4/2012quarterly$0.2612/14/201212/27/2012
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Covidien Ltd (NYSE:COV)
Insider Trades by Quarter for Covidien Ltd (NYSE:COV)
Insider Trades by Quarter for Covidien Ltd (NYSE:COV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/5/2014Michael SgrignariSVPSell25,795$103.48$2,669,266.60View SEC Filing  
12/3/2014Dennis H ReilleyDirectorSell10,521$101.39$1,066,724.19View SEC Filing  
11/17/2014Richard G Brown JrVPBuy5,300$94.44$500,532.00View SEC Filing  
11/7/2014Robert H BrustDirectorSell4,000$92.03$368,120.00View SEC Filing  
8/27/2014Coleman N Lannum IIIVPBuy3,338$87.23$291,173.74View SEC Filing  
8/26/2014Coleman N Lannum IIIVPBuy1,736$87.46$151,830.56View SEC Filing  
8/19/2014Coleman N Lannum IIIVPBuy1,720$87.82$151,050.40View SEC Filing  
8/18/2014Coleman N Lannum IIIVPBuy4,100$87.58$359,078.00View SEC Filing  
6/16/2014Jose E AlmeidaInsiderSell51,166$92.05$4,709,830.30View SEC Filing  
4/29/2014Brian Douglas KingVPSell15,569$70.11$1,091,542.59View SEC Filing  
3/28/2014Charles DockendorffCFOSell90,730$72.50$6,577,925.00View SEC Filing  
2/28/2014Jose AlmeidaInsiderSell50,000$72.00$3,600,000.00View SEC Filing  
2/13/2014Richard Brown, Jr.VPSell4,000$71.00$284,000.00View SEC Filing  
2/11/2014Brian Douglas KingVPSell17,946$70.00$1,256,220.00View SEC Filing  
2/11/2014Bryan HansonSVPSell32,480$69.97$2,272,625.60View SEC Filing  
1/29/2014Coleman Lannum IIIVPSell13,787$69.23$954,474.01View SEC Filing  
1/24/2014Richard Brown, Jr.VPSell4,000$70.00$280,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Covidien Ltd (NYSE:COV)
Latest Headlines for Covidien Ltd (NYSE:COV)
Source:

Social

Chart

Covidien Ltd (COV) Chart for Friday, October, 20, 2017

This page was last updated on 10/20/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.